Impact of long-term proton pump inhibitor therapy on gut microbiota in F344 rats: Pilot study

Gut and Liver

Volumn 10, Issue 6, 2016, Pages 896-901

  Shin, Cheol Min ^a   Kim, Nayoung ^a,b   Kim, Yong Sung ^c   Nam, Ryoung Hee ^a   Park, Ji Hyun ^b   Lee, Dong Ho ^a,b   Seok, Yeong Jae ^d   Kim, Yeon Ran ^d   Kim, Joo Hyon ^e   Kim, Jung Min ^f   Kim, Joo Sung ^b   Jung, Hyun Chae ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Wonkwang University School of Medicine   (South Korea)

^d Seoul National University   (South Korea)

^e SK Chemicals   (South Korea)

^f Daejeon University   (South Korea)

Author keywords

Clostridium; Gastrointestinal microbiome; Proton pump inhibitors; Small bowel intestinal overgrowth

Indexed keywords

LANSOPRAZOLE; RNA 16S; PROTON PUMP INHIBITOR;

16SRRNA GENE; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CLOSTRIDIUM; CONTROLLED STUDY; ESCHERICHIA; FECES ANALYSIS; FIRMICUTES; GENE SEQUENCE; INTESTINE FLORA; LACTOBACILLUS; LIMIT OF QUANTITATION; MALE; NONHUMAN; PASTEURELLA; PILOT STUDY; POPULATION ABUNDANCE; PROTEOBACTERIA; PYROSEQUENCING; RAT; STOOL CONSISTENCY; STOOL FREQUENCY; TERMINAL ILEUM; WEIGHT REDUCTION; ANIMAL; DNA SEQUENCE; DRUG EFFECTS; FISCHER 344 RAT; GENETICS; ILEUM; MICROBIOLOGY; PROCEDURES; TIME;

ANIMALS; GASTROINTESTINAL MICROBIOME; ILEUM; LANSOPRAZOLE; MALE; PILOT PROJECTS; PROTON PUMP INHIBITORS; RATS; RATS, INBRED F344; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; TIME;

EID: 84992649034     PISSN: 19762283     EISSN: 20051212     Source Type: Journal    
DOI: 10.5009/gnl15529     Document Type: Article

References (29)

1. Pham CQ, Regal RE, Bostwick TR, Knauf KS. Acid suppressive therapy use on an inpatient internal medicine service. Ann Pharmacother 2006; 40: 1261-1266.
2. Ramirez E, Lei SH, Borobia AM, et al. Overuse of PPIs in patients at admission, during treatment, and at discharge in a tertiary Spanish hospital. Curr Clin Pharmacol 2010; 5: 288-297.
3. Reimer C. Safety of long-term PPI therapy. Best Pract Res Clin Gastroenterol 2013; 27: 443-454.
4. Jo Y, Park E, Ahn SB, et al. A proton pump inhibitor's effect on bone metabolism mediated by osteoclast action in old age: A prospective randomized study. Gut Liver 2015; 9: 607-614.
5. Atkinson NS, Reynolds DJ, Travis SP. 'Lemonade legs': Why do some patients get profound hypomagnesaemia on proton-pump inhibitors? Intest Res 2015; 13: 227-232.
6. Lo WK, Chan WW. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: A meta-analysis. Clin Gastroenterol Hepatol 2013; 11: 483-490.
7. Ratuapli SK, Ellington TG, O'Neill MT, et al. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth. Am J Gastroenterol 2012; 107: 730-735.
8. Husebye E, Skar V, Høverstad T, Iversen T, Melby K. Abnormal intestinal motor patterns explain enteric colonization with gramnegative bacilli in late radiation enteropathy. Gastroenterology 1995; 109: 1078-1089.
9. Freedberg DE, Lebwohl B, Abrams JA. The impact of proton pump inhibitors on the human gastrointestinal microbiome. Clin Lab Med 2014; 34: 771-785.
10. Jo HJ, Kim N, Nam RH, et al. The effect of Cochinchina momordica seed extract on gastric acid secretion and morphologic change in aged rat stomach. Gut Liver 2013; 7: 560-568.
11. Huber T, Faulkner G, Hugenholtz P. Bellerophon: A program to detect chimeric sequences in multiple sequence alignments. Bioinformatics 2004; 20: 2317-2319.
12. Kim OS, Cho YJ, Lee K, et al. Introducing EzTaxon-e: A prokaryotic 16S rRNA gene sequence database with phylotypes that represent uncultured species. Int J Syst Evol Microbiol 2012; 62(Pt 3): 716-721.
13. Li XX, Wong GL, To KF, et al. Bacterial microbiota profiling in gastritis without Helicobacter pylori infection or non-steroidal anti-inflammatory drug use. PLoS One 2009; 4: E7985.
14. Gan KH, Geus WP, Lamers CB, Heijerman HG. Effect of omeprazole 40 mg once daily on intraduodenal and intragastric pH in H. pylori-negative healthy subjects. Dig Dis Sci 1997; 42: 2304-2309.
15. Hoffmann JC, Zeitz M. Small bowel disease in the elderly: Diarrhoea and malabsorption. Best Pract Res Clin Gastroenterol 2002; 16: 17-36.
16. Husebye E, Skar V, Høverstad T, Melby K. Fasting hypochlorhydria with gram positive gastric flora is highly prevalent in healthy old people. Gut 1992; 33: 1331-1337.
17. Mariat D, Firmesse O, Levenez F, et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol 2009; 9: 123.
18. Pimentel M, Chatterjee S, Chang C, et al. A new rat model links two contemporary theories in irritable bowel syndrome. Dig Dis Sci 2008; 53: 982-989.
19. Gerritsen J, Timmerman HM, Fuentes S, et al. Correlation between protection against sepsis by probiotic therapy and stimulation of a novel bacterial phylotype. Appl Environ Microbiol 2011; 77: 7749-7756.
20. Garcia-Mazcorro JF, Suchodolski JS, Jones KR, et al. Effect of the proton pump inhibitor omeprazole on the gastrointestinal bacterial microbiota of healthy dogs. FEMS Microbiol Ecol 2012; 80: 624-636.
21. Kanno T, Matsuki T, Oka M, et al. Gastric acid reduction leads to an alteration in lower intestinal microflora. Biochem Biophys Res Commun 2009; 381: 666-670.
22. Jakobsson HE, Jernberg C, Andersson AF, Sjölund-Karlsson M, Jansson JK, Engstrand L. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One 2010; 5: E9836.
23. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005; 102: 11070-11075.
24. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: Human gut microbes associated with obesity. Nature 2006; 444: 1022-1023.
25. Sweeney TE, Morton JM. The human gut microbiome: A review of the effect of obesity and surgically induced weight loss. JAMA Surg 2013; 148: 563-569.
26. Ward EK, Schuster DP, Stowers KH, et al. The effect of PPI use on human gut microbiota and weight loss in patients undergoing laparoscopic Roux-en-Y gastric bypass. Obes Surg 2014; 24: 1567-1571.
27. Sands SA, Tsau S, Yankee TM, Parker BL, Ericsson AC, LeVine SM. The effect of omeprazole on the development of experimental autoimmune encephalomyelitis in C57BL/6J and SJL/J mice. BMC Res Notes 2014; 7: 605.
28. Seto CT, Jeraldo P, Orenstein R, Chia N, DiBaise JK. Prolonged use of a proton pump inhibitor reduces microbial diversity: Implications for Clostridium difficile susceptibility. Microbiome 2014; 2: 42.
29. Parkes GC, Brostoff J, Whelan K, Sanderson JD. Gastrointestinal microbiota in irritable bowel syndrome: Their role in its pathogenesis and treatment. Am J Gastroenterol 2008; 103: 1557-1567.